Drug profile · INN
ardeparin sodium
NORMIFLO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ardeparin sodium (NORMIFLO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN ardeparin sodium
Brand NORMIFLO
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is ardeparin sodium?
ardeparin sodium (NORMIFLO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ardeparin sodium?
NORMIFLO is a marketed brand name for ardeparin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ardeparin sodium?
ardeparin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.